Eugenia Pedagogos

Double-Blind, Placebo-Controlled Study on the Effect of the Aldosterone Receptor Antagonist Spironolactone in Patients Who Have Persistent Proteinuria and Are on Long-Term Angiotensin-Converting Enzyme Inhibitor Therapy, with or without an Angiotensin II Receptor Blocker

Anastasia Chrysostomou, Eugenia Pedagogos, Lachlan MacGregor et al. · Clinical Journal of the American Society of Nephrology · 2006 · 210 citations

Pharmacy, Pharmacology, Pharmacotherapy +15

Finerenone in Patients With Chronic Kidney Disease and Type 2 Diabetes by Sodium–Glucose Cotransporter 2 Inhibitor Treatment: The FIDELITY Analysis

Peter Rossing, Stefan D. Anker, Gerasimos Filippatos et al. · Diabetes Care · 2022 · 199 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

Temporal distribution of arrhythmic events in chronic kidney disease: Highest incidence in the long interdialytic period

Michael Wong, Jonathan M. Kalman, Eugenia Pedagogos et al. · Heart Rhythm · 2015 · 115 citations

Medicine, Cardiology, Nephrology +15

Barriers to Timely Arteriovenous Fistula Creation: A Study of Providers and Patients

Pamela Lopez‐Vargas, Jonathan C. Craig, Martin Gallagher et al. · American Journal of Kidney Diseases · 2011 · 94 citations

Medicine, Surgery, Continuity Of Care +10

A Randomized Trial on the Effect of Phosphate Reduction on Vascular End Points in CKD (IMPROVE-CKD)

Nigel D. Toussaint, Eugenia Pedagogos, Nicole Lioufas et al. · Journal of the American Society of Nephrology · 2020 · 88 citations · Full text

Medicine, Nephrology, Pharmacotherapy +10